Rubio, Rodrigo E.
HRN: 12-12-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2023
CEFTAZIDIME 1GM (VIAL)
12/12/2023
12/19/2023
IV
1g
Q8
CAP MR, COPD In AE
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes